Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Phathom Pharmaceuticals, Inc. - Common Stock
(NQ:
PHAT
)
9.690
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Phathom Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Phathom Pharmaceuticals Announces Leadership Succession
April 01, 2025
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan)
March 31, 2025
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Traders are paying attention to the gapping stocks in Tuesday's session.
March 18, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Via
Chartmill
IHS Holding Posts Upbeat Earnings, Joins Tencent Music Entertainment, Elbit Systems And Other Big Stocks Moving Higher On Tuesday
March 18, 2025
Via
Benzinga
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 06, 2025
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025
February 24, 2025
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Earnings Scheduled For March 6, 2025
March 06, 2025
Via
Benzinga
Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference
January 29, 2025
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Top Biotech Short Squeeze Stocks
December 12, 2024
Investing in biotechnology stocks offers a unique opportunity for individuals looking to gain exposure to one of the most dynamic and innovative sectors of the market.
Via
Talk Markets
Topics
Stocks / Equities
Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets
December 11, 2024
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 07, 2024
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
November 04, 2024
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024
October 28, 2024
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting
October 27, 2024
From
Phathom Pharmaceuticals
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
October 03, 2024
Via
Benzinga
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
August 29, 2024
From
Phathom Pharmaceuticals
Via
GlobeNewswire
These Are The Top 3 Most-Shorted Stocks In August 2024; Here’s Why
August 21, 2024
Short-squeeze opportunities are tough to find. Combine market timing with fundamentals for these stocks.
Via
Talk Markets
Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants
August 19, 2024
From
Phathom Pharmaceuticals
Via
GlobeNewswire
PHAT Stock Earnings: Phathom Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
PHAT stock results show that Phathom Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Added to CVS Caremark Formularies for Commercially Insured Patients
July 30, 2024
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Phathom Pharmaceuticals to Report Second Quarter 2024 Financial Results and Provide Business Update on Thursday, August 8, 2024
July 29, 2024
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults
July 18, 2024
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Ready for Quick Gains? 7 Top Short-Squeeze Stocks to Watch Now
June 09, 2024
Each of the following seven heavily-shorted stocks may have what it takes to become one of the next big short squeeze stocks.
Via
InvestorPlace
Ride the Gamma Wave: 3 Stocks on the Verge of a Short Squeeze
June 07, 2024
Though short squeezes are never guaranteed, these three potential short squeeze stocks could provide generous returns if bought right.
Via
InvestorPlace
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
May 28, 2024
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting
May 15, 2024
From
Phathom Pharmaceuticals
Via
GlobeNewswire
The 3 Best Healthcare Stocks to Buy in May 2024
May 10, 2024
Healthcare firms can make large amounts of money, particularly in the U.S. Here are the three best healthcare stocks to buy now.
Via
InvestorPlace
PHAT Stock Earnings: Phathom Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
May 09, 2024
PHAT stock results show that Phathom Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From
Phathom Pharmaceuticals
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.